Cargando…
Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging
INTRODUCTION: There is an unmet need to develop noninvasive biomarkers to stratify patients in drug-radiotherapy trials. In this pilot study we investigated lung cancer radiotherapy response and toxicity blood biomarkers and correlated findings with tumor volume and proliferation imaging. PATIENTS A...
Autores principales: | Salem, Ahmed, Mistry, Hitesh, Backen, Alison, Hodgson, Clare, Koh, Pek, Dean, Emma, Priest, Lynsey, Haslett, Kate, Trigonis, Ioannis, Jackson, Alan, Asselin, Marie-Claude, Dive, Caroline, Renehan, Andrew, Faivre-Finn, Corinne, Blackhall, Fiona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927801/ https://www.ncbi.nlm.nih.gov/pubmed/29398577 http://dx.doi.org/10.1016/j.cllc.2017.12.002 |
Ejemplares similares
-
Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value
por: Walker, Michael J., et al.
Publicado: (2015) -
Early reduction in tumour [(18)F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone
por: Trigonis, Ioannis, et al.
Publicado: (2014) -
Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial
por: Salem, Ahmed, et al.
Publicado: (2018) -
The Rare YAP1 Subtype of SCLC Revisited in a Biobank of 39 Circulating Tumor Cell Patient Derived Explant Models: A Brief Report
por: Pearsall, Sarah M., et al.
Publicado: (2020) -
Reliability and prognostic value of radiomic features are highly dependent on choice of feature extraction platform
por: Fornacon-Wood, Isabella, et al.
Publicado: (2020)